The Effect of PinnoThin on Satiety and Food Intake

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status

Completed

Conditions

Obesity

Treatments

Dietary Supplement: PinnoThin

Study type

Interventional

Funder types

Other

Identifiers

NCT01034605
HumBio_Westerterp08

Details and patient eligibility

About

Based upon an increased secretion of gastrointestinal satiety hormones (CCK, GLP-1), PinnoThin is hypothesized to be more satiating, and to limit energy intake in humans. Therefore, the objective of this study is to investigate whether PinnoThin leads to an increase in satiety as determined by VAS ratings? Additionally, does PinnoThin consumed during breakfast, in comparison to placebo, in overweight women, lead to a decrease in energy intake during an ad libitum lunch?

Enrollment

40 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age over 18 and under 45
  • women
  • BMI over 23 and under 30
  • breakfast eaters

Exclusion criteria

  • men
  • age under 18 and over 45
  • BMI under 23 and over 30
  • use of medication
  • pregnant and breastfeeding

Trial design

40 participants in 1 patient group

inulin
Experimental group
Description:
oligofructose
Treatment:
Dietary Supplement: PinnoThin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems